Carcinoma Clinical Trials in Leiden, South Holland
5 recruitingLeiden, South Holland, Netherlands
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb470 enrolled277 locationsNCT07076121
Recruiting
Phase 2
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Renal Cell Carcinoma (RCC)
dr. Tom van der Hulle34 enrolled1 locationNCT07077161
Recruiting
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
CarcinomaSkin CancerBasal Cell Carcinoma+8 more
Maastricht University Medical Center80 enrolled8 locationsNCT05463757
Recruiting
Not Applicable
Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma
Colorectal Carcinoma (CRC)
Erasmus Medical Center200 enrolled5 locationsNCT06613581
Recruiting
Phase 4
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Lung CancerCarcinoma, Non-Small Cell LungDrug Monitoring+2 more
University Medical Center Groningen196 enrolled8 locationsNCT05525338